NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

NHS EnglandcontractContracts FinderRef CF-0121400D0O000000rwimUAA1SME suitablecomplete
View buyer

Estimated value

£17.3m

Awarded value

£17.3m

Awarded 04 Jan 2021

Suppliers

1

Lots

1

1 awarded

Published

11 Mar 2021

Deadline 08 Dec 2020

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →
TitleTypeValuePublished
Matrix - Desk Booking Systemcall off£105k08 May 2026
Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028call off£17k08 May 2026
ID&V Checking Servicecontract£150k08 May 2026
Xerox Managed Print renewal 26/27call off£127k08 May 2026
Manage Engine ServiceDesk Plus Licencescall off£29k08 May 2026
Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026contract£105k08 May 2026
Clinicals Run Maintain Transformcall off£38.0m10 Apr 2026
Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmescontract07 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiativescontract07 Apr 2026
CPIT System Integration to NHSE RAVScontract£500k01 Apr 2026

Other contracts awarded to Accord-UK Ltd,AstraZeneca,Cipla (EU) Ltd,Dr.Reddy's Laboratories (UK) Limited,Janssen-Cilag Ltd,Novartis Pharmaceuticals UK Ltd,Sandoz Ltd,Teva UK Limited,Thornton and Ross Ltd,Zentiva Pharma UK Ltd· 0

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →

No related contracts found.